-
1
SEE trial aimed to improve glaucoma medication adherence.
-
2
Enrolled 235 adults with self-reported poor adherence.
-
3
Intervention included in-person sessions and automated reminders.
-
4
Adherence improved from 63.9% to 77.6%.
-
5
Over half of SEE participants achieved ≥80% adherence.
-
6
Reduced glaucoma-related distress significantly.
-
7
Suggests personalized strategies are more effective than traditional methods.
Original Source(s)
Related Content
Haag-Streit Announces Global launch of METIS 3D Digital Heads-Up Module
Follows module's successful US debut at AAO 2025
April 3, 2026
-
2 min
The Power of Adjustability
Sitting Down With… Ron Kurtz, President and Chief Executive Officer, RxSight
by Julian Upton
April 2, 2026
-
9 min
When Corneal Nerves Fall Silent
Clinical study reveals age-related sensory decline of cornea in aniridia patients
April 2, 2026
-
4 min
